Advertisement
Home Tags Cancer: Breast

Tag: Cancer: Breast

The CYP3A7*1C allele appears to be associated with mortality and disease progression in specific cancers

CYP3A7*1C Allele Linked to Cancer Mortality, Progression

Associated with adverse outcomes in breast cancer, lung cancer, chronic lymphocytic leukemia
The 21-gene recurrence score (Oncotype DX) seems to accurately identify women with early-stage breast cancer who don't need chemotherapy

Gene Test IDs Breast CA Patients Who May Not Need Chemo

Analysis can help women who won't benefit from additional treatment to avoid side effects
Women with diabetes who take insulin appear to have a higher incidence of dense breasts

Insulin Treatment May Up Breast Density in Diabetes Patients

Women on insulin might need extra breast cancer screening
The drug combination of lapatinib (Tykerb) and trastuzumab (Herceptin) induces tumor regression or disappearance in 25 percent of human epidermal growth factor receptor 2 (HER2)-positive cancers in 11 days

Lapatinib + Trastuzumab May Rapidly Shrink Breast Tumors

Researchers say combo therapy works well for about one in four women with HER2+ breast cancer
For women with early-stage breast cancer

Targeted Radiation Shows Promise in Early Breast Cancer

Limited radiotherapy effective after low-risk tumors are removed, but questions remain
For women with mammography-negative dense breasts

Breast Cancer Detection With Ultrasound Tops Tomosynthesis

False-positive recall rate similar; findings in women with mammography-negative dense breasts
Presurgery high neutrophil to lymphocyte ratio is a prognostic variable of worse outcome in Caucasian patients with early breast cancer

High Neutrophil to Lymphocyte Ratio Prognostic in Breast Cancer

High NLR linked to worse prognosis in Caucasian patients with early breast cancer
Many women treated for early breast cancer overestimate the odds of distant recurrence

Women Often Overestimate Odds of Early Breast Cancer Spreading

Misperceptions lead to worry that harms quality of life, researcher says
From 2005 to 2013 there was a 36 percent increase in the overall rate of mastectomies

Thirty-Six Percent Increase in Mastectomies From 2005 to 2013

Bilateral mastectomies with cancer more than tripled and those without cancer more than doubled
Use of vaginal estrogen should be carefully considered by women with a history of estrogen-dependent breast cancer

ACOG: Vaginal Estrogen Can Be Used for Breast Cancer Survivors

Decision to use vaginal estrogen should be made with oncologist, after consideration of data